Back to Search
Ortho Tri-Cyclen Lo
by Janssen Pharmaceuticals IncContraceptionCOCP
DiscontinuedReference Drug

Estrogen

Ethinyl Estradiol

0.025Mg,0.025Mg,0.025Mg

Progestin

Norgestimate

0.18Mg,0.215Mg,0.25Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

Low/Reduced Androgenic

Approval Date

8/22/2002

Additives
None
Inactive Ingredients
lactosepregelatinized corn starchtitanium dioxidecarnauba waxcroscarmellose sodiumhypromellosemagnesium stearatemicrocrystalline cellulosepolyethylene glycolpurified waterFD & C Blue No. 2 Aluminum Lakepolysorbate 80ferric oxidetalc

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Glenmark Specialty Sa

Norgestimate And Ethinyl Estradiol

Lupin Pharmaceuticals Inc

Norgestimate And Ethinyl Estradiol

Amneal Pharmaceuticals Of New York Llc

Norgestimate And Ethinyl Estradiol

Barr Laboratories Inc

Tri Lo Sprintec

Lupin Pharmaceuticals, Inc

Tri-Lo Marzia

Xiromed Pharma Espana Sl

Tri-Lo-Estarylla

Novast Laboratories Ltd

Tri-Lo-Linyah

Aurobindo Pharma Limited

Tri-Lo-Mili

Have clinical questions about Ortho Tri-Cyclen Lo?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy